Suppr超能文献

胰岛素对大鼠肝癌细胞中胰岛素样生长因子作用的调节

Insulin regulation of insulin-like growth factor action in rat hepatoma cells.

作者信息

Heaton J H, Krett N L, Alvarez J M, Gelehrter T D, Romanus J A, Rechler M M

出版信息

J Biol Chem. 1984 Feb 25;259(4):2396-402.

PMID:6142041
Abstract

We have reported previously that insulin causes a complete but reversible desensitization to insulin action in rat hepatoma HTC cells in tissue culture, and that this insulin resistance is mediated by postbinding mechanisms rather than receptor down-regulation (Heaton, J. H., and Gelehrter, T. D. (1981) J. Biol. Chem. 256, 12257-12262). We report here that insulin causes a similar desensitization to the induction of tyrosine aminotransferase by the insulin-like growth factors IGF-I and IGF-II isolated from human plasma, and by multiplication-stimulating activity, the rat homologue of IGF-II. The results of both competition-binding studies and affinity cross-linking experiments indicate that insulin-like growth factors (IGFs) bind primarily to IGF receptors rather than to insulin receptors. The low concentrations at which these factors induce transaminase is consistent with their acting primarily via IGF receptors. This is confirmed by experiments utilizing anti-insulin receptor antibody which both inhibits 125I-insulin binding and shifts the concentration dependence of insulin induction of tyrosine aminotransferase to the right. This same immunoglobulin does not inhibit 125I-multiplication-stimulating activity binding and only minimally inhibits 125I-IGF-I binding. Anti-insulin receptor antibody also does not significantly shift the concentration dependence for the IGFs, suggesting that IGFs induce transaminase by acting via IGF receptors. Although insulin down regulates insulin receptors, it does not decrease IGF-I or IGF-II binding. We conclude that insulin causes desensitization of HTC cells to IGFs by affecting a postbinding step in IGF action, which may be common to the actions of both insulin and insulin-like growth factors.

摘要

我们之前曾报道,在组织培养中,胰岛素会使大鼠肝癌HTC细胞对胰岛素作用产生完全但可逆的脱敏,且这种胰岛素抵抗是由结合后机制介导的,而非受体下调(希顿,J. H.,和格勒尔特,T. D.(1981年)《生物化学杂志》256,12257 - 12262)。我们在此报道,胰岛素会使HTC细胞对从人血浆中分离出的胰岛素样生长因子IGF - I和IGF - II以及对增殖刺激活性(IGF - II的大鼠同源物)诱导酪氨酸转氨酶的作用产生类似的脱敏。竞争结合研究和亲和交联实验的结果均表明,胰岛素样生长因子(IGFs)主要与IGF受体结合,而非与胰岛素受体结合。这些因子诱导转氨酶的低浓度与其主要通过IGF受体起作用一致。利用抗胰岛素受体抗体的实验证实了这一点,该抗体既能抑制125I - 胰岛素结合,又能将胰岛素诱导酪氨酸转氨酶的浓度依赖性向右移动。同一免疫球蛋白不抑制125I - 增殖刺激活性结合,仅轻微抑制125I - IGF - I结合。抗胰岛素受体抗体也不会显著改变IGFs的浓度依赖性,这表明IGFs通过作用于IGF受体来诱导转氨酶。尽管胰岛素会下调胰岛素受体,但它不会降低IGF - I或IGF - II的结合。我们得出结论,胰岛素通过影响IGF作用中的一个结合后步骤,使HTC细胞对IGFs产生脱敏,这可能是胰岛素和胰岛素样生长因子作用的共同之处。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验